As of March 23, 2026, Camp4 Therapeutics's top three insider holders are Sciences Gp, Llc Enavate (TenPercentOwner, 3.79Mn shares), Andrew J. Schwab (Director, 2.94Mn shares), Partners Vi, Llc 5Am (TenPercentOwner, 2.94Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Sciences Gp, Llc Enavate | 0 | 3,785,802 | 17 Oct, 2024 | |
| Partners Vi, Llc 5Am | 0 | 2,941,176 | 15 Sep, 2025 | |
| Andrew J. Schwab | 0 | 2,941,176 | 15 Sep, 2025 | |
| Ventures Ii Gp, Llc Northpond | 0 | 763,636 | 17 Oct, 2024 | |
| Equity Partners Bio I, L.L.C. Ah | 0 | 545,454 | 17 Oct, 2024 | |
| Josh Mandel-Brehm | Chief Executive Officer | 278,417 | 0 | 11 Sep, 2025 |
| Management Co. Vii, L.L.C. Polaris | 0 | 197,661 | 11 Sep, 2025 | |
| Amir Nashat | 0 | 197,661 | 11 Sep, 2025 | |
| Richard A Young | 170,010 | 0 | 11 Sep, 2025 | |
| Steven H Holtzman | 108,946 | 0 | 15 Oct, 2024 | |
| Kelly Gold | Chief Financial Officer | 67,877 | 0 | 11 Sep, 2025 |
| Yuri Maricich | Chief Medical Officer | 6,060 | 0 | 11 Sep, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 11 Dec, 2025 | Kelly Gold | Stock Option (Right to Buy) | A | 190,000 | $0.00 | 190,000 | D | A |
| 11 Dec, 2025 | Yuri Maricich | Stock Option (Right to Buy) | A | 190,000 | $0.00 | 190,000 | D | A |
| 11 Dec, 2025 | Daniel Tardiff | Stock Option (Right to Buy) | A | 145,500 | $0.00 | 145,500 | D | A |
| 11 Dec, 2025 | Josh Mandel-Brehm | Stock Option (Right to Buy) | A | 425,000 | $0.00 | 425,000 | D | A |
| 11 Sep, 2025 | Andrew J. Schwab | Common Stock | A | 2,941,176 | $1.53 | 2,941,176 | I | A |
| 11 Sep, 2025 | Partners Vi, Llc 5Am | Common Stock | A | 2,941,176 | $1.53 | 2,941,176 | I | P |
| 11 Sep, 2025 | Richard A Young | Common Stock | A | 15,151 | $1.65 | 170,010 | D | P |
| 11 Sep, 2025 | Kelly Gold | Common Stock | A | 6,060 | $1.65 | 67,877 | D | P |
| 11 Sep, 2025 | Josh Mandel-Brehm | Common Stock | A | 6,060 | $1.65 | 278,417 | D | P |
| 11 Sep, 2025 | Yuri Maricich | Common Stock | A | 6,060 | $1.65 | 6,060 | D | P |
| 11 Sep, 2025 | Management Co. Vii, L.L.C. Polaris | Common Stock | A | 1,221,721 | $1.53 | 2,825,500 | I | P |
| 11 Sep, 2025 | Amir Nashat | Common Stock | A | 1,221,721 | $1.53 | 2,825,500 | I | P |
| 11 Sep, 2025 | Management Co. Vii, L.L.C. Polaris | Common Stock | A | 85,468 | $1.53 | 197,661 | I | P |
| 11 Sep, 2025 | Amir Nashat | Common Stock | A | 85,468 | $1.53 | 197,661 | I | P |
| 25 Jun, 2025 | Steven H Holtzman | Stock Option (Right to Buy) | A | 9,000 | $0.00 | 9,000 | D | A |
| 25 Jun, 2025 | Ravi I. Thadhani | Stock Option (Right to Buy) | A | 9,000 | $0.00 | 9,000 | D | A |
| 25 Jun, 2025 | Paula Ragan | Stock Option (Right to Buy) | A | 9,000 | $0.00 | 9,000 | D | A |
| 25 Jun, 2025 | Richard A Young | Stock Option (Right to Buy) | A | 9,000 | $0.00 | 9,000 | D | A |
| 25 Jun, 2025 | Michael J Higgins | Stock Option (Right to Buy) | A | 9,000 | $0.00 | 9,000 | D | A |
| 25 Jun, 2025 | James P Boylan | Stock Option (Right to Buy) | A | 9,000 | $0.00 | 9,000 | D | A |